Fig. 1 · Structure

Documents & Downloads

Palmatine chloride

Cat. No. A10692 CAS 10605-02-4
Palmatine chloride is a protoberberine alkaloid that is isolated from medicinal herbs like Coptis chinensis Franch.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
IDO-1 3 μM (IC50, HEK 293-hIDO-1)
IDO-1 157 μM (IC50, rhIDO-1)
WNV NS2B-NS3 IC50 96 μM

Cellular Effect

Cell Line Activity Value Description Reference
G-402 GI50 83.14 μM Growth inhibition against human G402 cells after 48 hrs by MTT assay [PMID: 21401114]
HCT-116 IC50 > 100 μM Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay [PMID: 28359045]
HepG2 IC50 > 100 μM Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay [PMID: 28359045]
HL-60 IC50 > 100 μM Cytotoxicity against human HL60 cells after 72 hrs by MTT assay [PMID: 28359045]
KM12C IC50 393 μM Inhibition of cell proliferation of human KM12C cells incubated for 15 hrs by MTT assay [PMID: 32391701]
L02 IC50 > 100 μM Cytotoxicity against human LO2 cells after 72 hrs by MTT assay [PMID: 28359045]
SMMC-7721 IC50 > 100 μM Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay [PMID: 28359045]

Palmatine chloride Research Summary

This section summarizes 2 in vitro studies and 1 in vivo study of Palmatine chloride from 2 published references. In vitro models include AChE from electric eel; M. canis.

Palmatine chloride In Vitro Studies

Palmatine chloride was evaluated against electric eel AChE, yielding an inhibition IC50 of 5.21 ± 0.48 mg/mL. In an agar-diffusion study against M. canis, Palmatine chloride had a reported MIC of 1 mg/mL. [1,2]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Palmatine Inhibition of Electric Eel AChE

Cell-based study · AChE from electric eel [1]

Palmatine chloride was evaluated against AChE from electric eel, with DMSO as the negative control. The AChE inhibition IC50 was 5.21 ± 0.48 mg/mL.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
IC50 AChE Inhibition (mg/mL)IC50 5.21 ± 0.48 mg/mL[1]

Literature-Reported Treatment Conditions

Exposure duration
incubate at room temperature for 3 min
Reported limits
Not stated in the sentences used: dose, route, vehicle.
Methods and source locations

Compound reported in the paper: Palmatine chloride; Compound label in the paper: Palmatine

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

4. Materials and Methods > 4.6. AChE Assay (S55, S58, S60, S61); Table 1 (T1.h1, T1.r12)

IC50 AChE Inhibition (mg/mL): IC50 AChE Inhibition (mg/mL); comparator: DMSO was used as negative control in all experiments — Table 1 (T1.h1, T1.r12)

Palmatine Inhibition of M. canis Growth

Cell-based study · M. canis [2]

Palmatine chloride was evaluated against M. canis using the agar-diffusion method, with clotrimazole as the positive control. The reported MIC was 1 mg/mL.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
the lowest concentration of berberine hydrochloride, palmatine hydrochloride, or clotrimazole required to inhibit fungal growthMIC 1 mg/mL[2]

Literature-Reported Treatment Conditions

Treatment concentration
0, 0.5, 1.0, 1.5, 2.0, 2.5, and 3 mg/mL
Exposure duration
at 28 °C for 72 h
Method
agar-diffusion method
Vehicle
dimethyl sulphoxide
Methods and source locations

Compound reported in the paper: Palmatine chloride; Compound label in the paper: Palmatine

Evidence for Palmatine chloride as the hydrochloride form reported in the paper, not the free base/neutral form supplied as A10692; no salt equivalence, dose conversion or lot validation.

Methods > In vitro antifungal effect of berberine hydrochloride and palmatine hydrochloride > Fungal organism (S3); Methods > Determination of the minimum inhibitory concentration (MIC) (S9, S10, S12, S13, S15, S16); Results > MICs of berberine or palmatine and growth curves (S70)

the lowest concentration of berberine hydrochloride, palmatine hydrochloride, or clotrimazole required to inhibit fungal growth: the lowest concentration of berberine hydrochloride, palmatine hydrochloride, or clotrimazole required to inhibit fungal growth; comparator: Clotrimazole served as the positive control. — Methods > Determination of the minimum inhibitory concentration (MIC) (S16); Results > MICs of berberine or palmatine and growth curves (S70)

Palmatine chloride In Vivo Studies

Palmatine chloride was administered at 1 mL of 1 mg/mL in white male New Zealand rabbits with dermatophytosis. At 7 d, clinical evaluation showed significant recovery of skin lesions in all treatment groups compared with the DMSO group (P < 0.05). [2]

Palmatine in Rabbit Dermatophytosis

Animal study · white, male New Zealand rabbits; Dermatophytosis; 10 rabbits in each group [2]

Palmatine chloride was evaluated in white male New Zealand rabbits with dermatophytosis in a design involving other interventions. At 7 d, clinical evaluation showed significant recovery of skin lesions in all treatment groups compared with the DMSO group.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Clinical evaluationReported result At 7 d, significant recovery of skin lesions was observed in all treatment groups compared with the DMSO group (P < 0.05).[2]

Conditions shared by the study groups

Treatment course
After 3 d; repeated each day for 3 d
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Palmatine chloride 1 mL of 1 mg/mLDMSO groupAt 7 d, significant recovery of skin lesions was observed in all treatment groups compared with the DMSO group (P < 0.05).[2]
Palmatine chloride 1 mL of 1 mg/mL
Model: white, male New Zealand rabbits; Dermatophytosis; 10 rabbits in each group
Reported limits: Not stated in the sentences used: route, vehicle.
Methods and source locations

Compound reported in the paper: Palmatine chloride; Compound label in the paper: Palmatine

Evidence for Palmatine chloride as the hydrochloride form reported in the paper, not the free base/neutral form supplied as A10692; no salt equivalence, dose conversion or lot validation.

Methods > Experimental animals (S49, S51); Methods > In-vivo antifungal assay (S53, S54, S55, S56, S57, S59, S61); Results > In vivo antifungal assay (S100); Fig. 1 legend (S109); Fig. 2 legend (S110); Fig. 6 legend (S129)

Clinical evaluation: Clinical evaluation; comparator: DMSO group — Methods > In-vivo antifungal assay (S61); Results > In vivo antifungal assay (S100)

Palmatine chloride 1 mL of 1 mg/mL · Methods > In-vivo antifungal assay (S57, S59); Results > In vivo antifungal assay (S100)

Specifications

Manufacturer Adooq Bioscience
CAS Number 10605-02-4
Formula C21H22NO4.Cl
Molecular Weight 387.9
Synonyms Palmatine hydrochloride
SMILES
COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC.[Cl-]

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 71 mg/mL (183.05 mM)
Water 5 mg/mL (12.89 mM)
Ethanol Warmed: 13 mg/mL (33.51 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Palmatine chloride Research References

  1. [1] Kaufmann D, Kaur Dogra A, Tahrani A, et al. Extracts from Traditional Chinese Medicinal Plants Inhibit Acetylcholinesterase, a Known Alzheimer's Disease Target. Molecules (2016). PMID: 27589716 DOI: 10.3390/molecules21091161 Source material
  2. [2] Xiao CW, Ji QA, Wei Q, et al. Antifungal activity of berberine hydrochloride and palmatine hydrochloride against Microsporum canis -induced dermatitis in rabbits and underlying mechanism. BMC Complement Altern Med (2015). PMID: 26054937 DOI: 10.1186/s12906-015-0680-x Source material

Added to your cart

View Cart Checkout
Loading...